Analyzing outcomes from the COVID-19, influenza, and pneumococcal vaccines, researchers explored the effectiveness and patient hesitancy surrounding each vaccine.
The introduction of the COVID-19 vaccine created an increased number of non-COVID-19 vaccine refusals amongst people living with HIV (PLWH), while a similar population also proved to be significantly nonadherent regarding the COVID-19 vaccination schedule. Regarding vaccine effectiveness, the pneumococcal conjugate vaccine and a high-dose quadrivalent inactivated influenza vaccine both proved to be significantly effective for PLWH.
“The prevalence of vaccine hesitancy has been rising over the last several years and was exacerbated by the COVID-19 epidemic with the introduction of the novel COVID-19 vaccines. There are concerns that immunosuppressed individuals such as HIV patients may also demonstrate vaccine hesitancy to recommended non-COVID-19 vaccines,” wrote authors of a poster presented at IDWeek 2024.
PLWH are at more severe risk of contracting infectious diseases and are advised to stay up to date with all recommended vaccinations. By staying protected against diseases like pneumococcal infections, influenza, and COVID-19, PLWH deplete their risk of hospitalization. However, with vaccine hesitancy at unprecedented levels since the COVID-19 pandemic, researchers focused on PLWH to further understand vaccine hesitancy and effectiveness among one of the most at-risk populations.
Read the full analysis here.
Source : Drug Topics
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.